- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04636346
COMPASS: A Group ACT Program for Cancer Patients Treated at UCSF
December 15, 2020 updated by: University of California, San Francisco
Evaluation of Compass: A Group Clinical Program in Psycho-Oncology Using Acceptance and Commitment Therapy to Address Fear of Recurrence/Progression in Cancer Survivors
Cancer Center Psychosocial services (Psycho-Oncology) offers group psychoeducational and behavioral programs as part of its clinical service for cancer patients and services at the Helen Diller Family Comprehensive Cancer Center.
Clinical outcomes and acceptability/feasibility and implementation process data from these programs are routinely gathered in an effort to engage in continuous quality improvement for the department.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
For this project, the study team is proposing to retrospectively analyze a de-identified data set of these data to report on pilot data on preliminary outcomes, acceptability and feasibility of the implementation of the COMPASS: Acting Mindfully for a Valued Life, based upon Acceptance and Commitment Therapy, an evidence-based behavioral intervention and facilitated by a licensed clinical psychologist in our department.
This intervention was implemented as a series of clinical offerings for seven 7-session groups between September 2015 and October 2018 for 113 individual cancer patients and survivors.
Outcomes measured include anxiety, depression, fear of recurrence, psychological flexibility, mindfulness; values based living, and quality of life.
Participants completed surveys at 4 time points, pre and post, and two followup time points.
Measures of demographics, satisfaction and feasibility/acceptability were also collected.
Insights gathered from this study will be used to inform articles, grant applications and conference presentations on the implementation of behavioral interventions for cancer patients and survivors.
Study Type
Observational
Enrollment (Actual)
129
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The population studied will include the participants of the COMPASS Program offered by the Cancer Center Psychosocial services (Psycho-Oncology) that consented to having their responses for the surveys to be used for research purposes.
The participants of COMPASS were adult cancer patients across different cancer types.
Participants that had previously consented to having their responses to the surveys kept for research purposes will have their responses accessed and kept as a part of a de-identified data set.
No direct subject contact will be included
Description
Inclusion Criteria:
- English-speaking
- Treated for any kind of cancer at University of California, San Francisco
- Sufficient cognitive ability to participate in group activities as determined by their attending medical oncologist or surgeon
Exclusion Criteria:
- Non-English speaking
- Treated elsewhere for cancer
- Psychiatric illness that would affect the ability to participate in a group activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
COMPASS (Psychoeducational / Behavioral Program)
Group Acceptance and Commitment Therapy program as part of clinical service for cancer patients
|
Seven group sessions
Outcomes measured include anxiety, depression, fear of recurrence, psychological flexibility, mindfulness; values based living, and quality of life.
Participants completed surveys at 4 time points, pre and post, and two follow-up time points.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the Patient Reported Outcome Measurement Information System (PROMIS) Anxiety Short Form scores over time
Time Frame: Up to 1 year
|
The PROMIS Anxiety Short form consists of 2 items addressing patient anxiety with item response scores ranging from 1 (never) to 5 (Always).
Raw scores are converted to scaled T-scores with higher scores indicating a greater level of anxiety.
Significant changes over time and trends in patient reported outcomes will be analyzed via student's T-test.
|
Up to 1 year
|
|
Changes in the Patient Reported Outcome Measurement Information System (PROMIS) Depression Short Form scores over time
Time Frame: Up to 1 year
|
The PROMIS Depression Short form consists of 4 items addressing patient depression with item response scores ranging from 1 (never) to 5 (Always).
Raw scores are converted to scaled T-scores with higher scores indicating a greater level of depression.
Significant changes over time and trends in patient reported outcomes will be analyzed via student's T-test.
|
Up to 1 year
|
|
Changes in Acceptance and Action Questionnaire II (AAQ-II) scores over time
Time Frame: Up to 1 year
|
The AAQ-II is a 7 item questionnaire used to track how participants are doing with applying psychological flexibility skills in their daily life.
Item scores range from 1 ("never true") to 7 ("always true":), and total scores are computed by adding up responses for each question.
Higher total scores mean less flexibility, while lower total scores mean more flexibility.
|
Up to 1 year
|
|
Changes in the Functional Assessment of Cancer Therapy scale (FACT-G) scores over time
Time Frame: Up to 1 year
|
The FACT-G is a 27-item questionnaire designed to measure four domains of health related quality of life (HRQOL) in cancer patients with 4 domains of interest: Physical, social, emotional, and functional well-being.
Each tem response score ranges from 0 (not at all) to 5 (very much).
The total score is a sum of the subscale scores, with a range from 0 - 108.
The higher the score, the better the HRQOL.
|
Up to 1 year
|
|
Changes in the Valuing Questionnaire (VQ) scores over time
Time Frame: Up to 1 year
|
The VQ is a 10-item scale designed to measure how consistently an individual has been living with their self-determined values and is helpful when administered during a course of Acceptance and Commitment Therapy (ACT).
Two subscale scores are measured: Progress and Obstruction.
Progress items (Range = 0 to 30) are defined as enactment and perseverance in living consistently with one's values.
Higher scores represent a closer alignment between one's internal values and one's actions.
Obstruction (Range = 0 to 30) represents the extent to which various disruptions "got in the way" of valued living.
Higher scores represent more interference with living consistently with one's values.
Total scores are calculated by summing the raw scores and calculating percentile ranks.
When used as a monitoring tool during a course of ACT, successful treatment is indicated by increasing Progress Scores and decreasing Obstruction Scores.
|
Up to 1 year
|
|
Changes in The Fear of Cancer Recurrence Index (FCRI) severity subscale scores over time
Time Frame: Up to 1 year
|
The nine-item FCRI evaluates the presence and severity of intrusive thoughts associated with FCR.
Each item is rated on a Likert scale ranging from 0 ("not at all" or "never") to 4 ("a great deal' or "all the time").
A higher score indicates higher levels of FCR.
|
Up to 1 year
|
|
Changes in the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being (FACIT-SP-12) scores over time
Time Frame: Up to 1 year
|
The FACIT-SP-12 is a 12 item questionnaire which measures a participants spiritual well-being for the past 7 days.
Item responses range from 0 (not at all) to 4 (very much).
The sum of the item scores are used to calculate a total FACIT-SP-12 score ranging from 0 to 48.
The higher the score, the better the QOL/spiritual well-being.
|
Up to 1 year
|
|
Changes in Five Facet Mindfulness Questionnaire (FFMQ) scores over time
Time Frame: Up to 1 year
|
The FFMQ is a 39-item questionnaire that measures five factors which represent elements of mindfulness.
The five facets are Observing, Describing, Acting with awareness, Non-judging of inner experience, and Non-reactivity to inner experience.
Item scores range from 1 ("never or very rarely true") to 5 ("very often or always true":), and total scores are computed by adding up responses for the questions that fall into each facet, for a range of 8-40 per facet with the exception of the Non-react scores which range from 7-35.
Higher scores on the Observe, React, and Non-react facets indicate higher levels of mindfulness and higher scores on the Act with Awareness and Non-judge items indicate less mindfulness.
|
Up to 1 year
|
|
Changes in Happiness Index Profile (HI/P10) scores over time
Time Frame: Up to 1 year
|
The HI/P10 is a 10-item questionnaire assessing positive affect, intention, and resiliency.
Each item is scored from 0 (strongly disagree) to 10 (strongly agree).
HI/P10 scores are calculated by adding the scores for each item to generate a total score out of 100.
|
Up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Margaret Chesney, PhD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 24, 2020
Primary Completion (Actual)
December 14, 2020
Study Completion (Actual)
December 14, 2020
Study Registration Dates
First Submitted
November 13, 2020
First Submitted That Met QC Criteria
November 13, 2020
First Posted (Actual)
November 19, 2020
Study Record Updates
Last Update Posted (Actual)
December 17, 2020
Last Update Submitted That Met QC Criteria
December 15, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 19805
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Acceptance and Commitment Therapy
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
Universidade Federal do ParanáActive, not recruitingObsessive-Compulsive DisorderBrazil
-
University of CoimbraUnknown
-
Texas Tech UniversityRecruitingGrief | Anxiety Disorder Generalized | Depression in AdultsUnited States
-
Ataturk UniversityNot yet recruitingChronic Mental DisordersTurkey
-
Universiti Sains MalaysiaRecruitingBreast Cancer FemaleMalaysia
-
University of CyprusNot yet recruitingDepression | Anxiety Disorders | Post Traumatic Stress Disorder
-
University of TromsoThe Royal Norwegian Ministry of HealthCompleted
-
University of NottinghamNottinghamshire Healthcare NHS Foundation Trust; Derbyshire Healthcare NHS...Completed
-
University of Alabama at BirminghamWithdrawn